Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Gomez

Showing results (71-80 of 231) with videos related to

Pageof 24
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 17, 2020
An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancerChonnipa Nantavithya, Daniel R Gomez, Joe Y Chang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2019
Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLCAmy C Moreno, Bryan Fellman, Brian P Hobbs, et al.
Advances in Radiation Oncology|September 12, 2022
Prospective Clinical Evaluation of Integrating a Radiation Anatomist for Contouring in Routine Radiation Treatment PlanningHelen Zhang, Ifeanyirochukwu Onochie, Lara Hilal, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 2014
Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomesSarah McAvoy, Katherine Ciura, Caimiao Wei, et al.
American Journal of Clinical Oncology|November 5, 2015
Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival AnalysisJidong Hong, Zhongxing Liao, Yan Zhuang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2015
Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survivalDaniel R Gomez, Kai-Ping Liao, Stephen G Swisher, et al.
Neuro-Oncology|August 2, 2005
High failure rate in spinal ependymomas with long-term follow-upDaniel R Gomez, Brian T Missett, William M Wara, et al.
American Journal of Surgery|March 12, 2023
Trends in location of death for individuals with metastatic lung cancer in the United StatesUrvish Jain, Bhav Jain, Edward Christopher Dee, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2013
Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancerDaniel R Gomez, Michael Gillin, Zhongxing Liao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 25, 2014
Acute phase response before treatment predicts radiation esophagitis in non-small cell lung cancerChad Tang, Zhongxing Liao, Yan Zhuang, et al.
Pageof 24

Showing results (71-80 of 231) with videos related to

Sort By:
Pageof 24
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 17, 2020
An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancerChonnipa Nantavithya, Daniel R Gomez, Joe Y Chang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2019
Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLCAmy C Moreno, Bryan Fellman, Brian P Hobbs, et al.
Advances in Radiation Oncology|September 12, 2022
Prospective Clinical Evaluation of Integrating a Radiation Anatomist for Contouring in Routine Radiation Treatment PlanningHelen Zhang, Ifeanyirochukwu Onochie, Lara Hilal, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 2014
Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomesSarah McAvoy, Katherine Ciura, Caimiao Wei, et al.
American Journal of Clinical Oncology|November 5, 2015
Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival AnalysisJidong Hong, Zhongxing Liao, Yan Zhuang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2015
Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survivalDaniel R Gomez, Kai-Ping Liao, Stephen G Swisher, et al.
Neuro-Oncology|August 2, 2005
High failure rate in spinal ependymomas with long-term follow-upDaniel R Gomez, Brian T Missett, William M Wara, et al.
American Journal of Surgery|March 12, 2023
Trends in location of death for individuals with metastatic lung cancer in the United StatesUrvish Jain, Bhav Jain, Edward Christopher Dee, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2013
Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancerDaniel R Gomez, Michael Gillin, Zhongxing Liao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 25, 2014
Acute phase response before treatment predicts radiation esophagitis in non-small cell lung cancerChad Tang, Zhongxing Liao, Yan Zhuang, et al.
Pageof 24